Immunogenicity and Safety of a Booster Dose of the SpikoGen COVID-19 Vaccine
Clinical trial NCT05175625 · COMPLETED
Trial details
- NCT number
- NCT05175625
- Sponsor
- Cinnagen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-15
- Primary completion
- 2021-12-30
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.